ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmacodynamic (PD) Biomarkers Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-34Q13414
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmacodynamic PD Biomarkers Market Research Report 2023
BUY CHAPTERS

Global Pharmacodynamic (PD) Biomarkers Market Research Report 2025

Code: QYRE-Auto-34Q13414
Report
February 2025
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thermo Fisher Scientific
Merck
Bio Rad Laboratories
Qiagen NV
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies

Pharmacodynamic (PD) Biomarkers Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmacodynamic (PD) Biomarkers Market

Pharmacodynamic (PD) Biomarkers Market

The global market for Pharmacodynamic (PD) Biomarkers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacodynamic (PD) Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacodynamic (PD) Biomarkers.
The Pharmacodynamic (PD) Biomarkers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmacodynamic (PD) Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacodynamic (PD) Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmacodynamic (PD) Biomarkers Market Report

Report Metric Details
Report Name Pharmacodynamic (PD) Biomarkers Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Merck, Bio-Rad Laboratories, QIAGEN, Roche, Danaher Corporation, Siemens Healthcare, Abbott, Agilent Technologies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmacodynamic (PD) Biomarkers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmacodynamic (PD) Biomarkers Market report?

Ans: The main players in the Pharmacodynamic (PD) Biomarkers Market are Thermo Fisher Scientific, Merck, Bio-Rad Laboratories, QIAGEN, Roche, Danaher Corporation, Siemens Healthcare, Abbott, Agilent Technologies

What are the Application segmentation covered in the Pharmacodynamic (PD) Biomarkers Market report?

Ans: The Applications covered in the Pharmacodynamic (PD) Biomarkers Market report are Diagnostics, Drug Discovery, Personalized Medicine, Others

What are the Type segmentation covered in the Pharmacodynamic (PD) Biomarkers Market report?

Ans: The Types covered in the Pharmacodynamic (PD) Biomarkers Market report are Exposure Biomarkers, Effect Biomarkers, Susceptibility Biomarkers

Recommended Reports

Pharmaceutical Diagnostics

Pharmaceutical Research

Diagnostics & Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Exposure Biomarkers
1.2.3 Effect Biomarkers
1.2.4 Susceptibility Biomarkers
1.3 Market by Application
1.3.1 Global Pharmacodynamic (PD) Biomarkers Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacodynamic (PD) Biomarkers Market Perspective (2020-2031)
2.2 Global Pharmacodynamic (PD) Biomarkers Growth Trends by Region
2.2.1 Global Pharmacodynamic (PD) Biomarkers Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmacodynamic (PD) Biomarkers Historic Market Size by Region (2020-2025)
2.2.3 Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Region (2026-2031)
2.3 Pharmacodynamic (PD) Biomarkers Market Dynamics
2.3.1 Pharmacodynamic (PD) Biomarkers Industry Trends
2.3.2 Pharmacodynamic (PD) Biomarkers Market Drivers
2.3.3 Pharmacodynamic (PD) Biomarkers Market Challenges
2.3.4 Pharmacodynamic (PD) Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacodynamic (PD) Biomarkers Players by Revenue
3.1.1 Global Top Pharmacodynamic (PD) Biomarkers Players by Revenue (2020-2025)
3.1.2 Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Players (2020-2025)
3.2 Global Pharmacodynamic (PD) Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmacodynamic (PD) Biomarkers Revenue
3.4 Global Pharmacodynamic (PD) Biomarkers Market Concentration Ratio
3.4.1 Global Pharmacodynamic (PD) Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacodynamic (PD) Biomarkers Revenue in 2024
3.5 Global Key Players of Pharmacodynamic (PD) Biomarkers Head office and Area Served
3.6 Global Key Players of Pharmacodynamic (PD) Biomarkers, Product and Application
3.7 Global Key Players of Pharmacodynamic (PD) Biomarkers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacodynamic (PD) Biomarkers Breakdown Data by Type
4.1 Global Pharmacodynamic (PD) Biomarkers Historic Market Size by Type (2020-2025)
4.2 Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Type (2026-2031)
5 Pharmacodynamic (PD) Biomarkers Breakdown Data by Application
5.1 Global Pharmacodynamic (PD) Biomarkers Historic Market Size by Application (2020-2025)
5.2 Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmacodynamic (PD) Biomarkers Market Size (2020-2031)
6.2 North America Pharmacodynamic (PD) Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2020-2025)
6.4 North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacodynamic (PD) Biomarkers Market Size (2020-2031)
7.2 Europe Pharmacodynamic (PD) Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2020-2025)
7.4 Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size (2020-2031)
8.2 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacodynamic (PD) Biomarkers Market Size (2020-2031)
9.2 Latin America Pharmacodynamic (PD) Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2020-2025)
9.4 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size (2020-2031)
10.2 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Introduction
11.1.4 Thermo Fisher Scientific Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Pharmacodynamic (PD) Biomarkers Introduction
11.2.4 Merck Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Introduction
11.3.4 Bio-Rad Laboratories Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Pharmacodynamic (PD) Biomarkers Introduction
11.4.4 QIAGEN Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
11.4.5 QIAGEN Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Pharmacodynamic (PD) Biomarkers Introduction
11.5.4 Roche Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Details
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Pharmacodynamic (PD) Biomarkers Introduction
11.6.4 Danaher Corporation Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
11.6.5 Danaher Corporation Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Details
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Pharmacodynamic (PD) Biomarkers Introduction
11.7.4 Siemens Healthcare Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
11.7.5 Siemens Healthcare Recent Development
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Pharmacodynamic (PD) Biomarkers Introduction
11.8.4 Abbott Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
11.8.5 Abbott Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Pharmacodynamic (PD) Biomarkers Introduction
11.9.4 Agilent Technologies Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
11.9.5 Agilent Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Thermo Fisher Scientific
Merck
Bio Rad Laboratories
Qiagen NV
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
List of Tables
 Table 1. Global Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Exposure Biomarkers
 Table 3. Key Players of Effect Biomarkers
 Table 4. Key Players of Susceptibility Biomarkers
 Table 5. Global Pharmacodynamic (PD) Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmacodynamic (PD) Biomarkers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Pharmacodynamic (PD) Biomarkers Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Pharmacodynamic (PD) Biomarkers Market Share by Region (2020-2025)
 Table 9. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Pharmacodynamic (PD) Biomarkers Market Share by Region (2026-2031)
 Table 11. Pharmacodynamic (PD) Biomarkers Market Trends
 Table 12. Pharmacodynamic (PD) Biomarkers Market Drivers
 Table 13. Pharmacodynamic (PD) Biomarkers Market Challenges
 Table 14. Pharmacodynamic (PD) Biomarkers Market Restraints
 Table 15. Global Pharmacodynamic (PD) Biomarkers Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Pharmacodynamic (PD) Biomarkers Market Share by Players (2020-2025)
 Table 17. Global Top Pharmacodynamic (PD) Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacodynamic (PD) Biomarkers as of 2024)
 Table 18. Ranking of Global Top Pharmacodynamic (PD) Biomarkers Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Pharmacodynamic (PD) Biomarkers Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Pharmacodynamic (PD) Biomarkers, Headquarters and Area Served
 Table 21. Global Key Players of Pharmacodynamic (PD) Biomarkers, Product and Application
 Table 22. Global Key Players of Pharmacodynamic (PD) Biomarkers, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Pharmacodynamic (PD) Biomarkers Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Type (2020-2025)
 Table 26. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Type (2026-2031)
 Table 28. Global Pharmacodynamic (PD) Biomarkers Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Application (2020-2025)
 Table 30. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Application (2026-2031)
 Table 32. North America Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Thermo Fisher Scientific Company Details
 Table 48. Thermo Fisher Scientific Business Overview
 Table 49. Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Product
 Table 50. Thermo Fisher Scientific Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025) & (US$ Million)
 Table 51. Thermo Fisher Scientific Recent Development
 Table 52. Merck Company Details
 Table 53. Merck Business Overview
 Table 54. Merck Pharmacodynamic (PD) Biomarkers Product
 Table 55. Merck Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025) & (US$ Million)
 Table 56. Merck Recent Development
 Table 57. Bio-Rad Laboratories Company Details
 Table 58. Bio-Rad Laboratories Business Overview
 Table 59. Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Product
 Table 60. Bio-Rad Laboratories Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025) & (US$ Million)
 Table 61. Bio-Rad Laboratories Recent Development
 Table 62. QIAGEN Company Details
 Table 63. QIAGEN Business Overview
 Table 64. QIAGEN Pharmacodynamic (PD) Biomarkers Product
 Table 65. QIAGEN Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025) & (US$ Million)
 Table 66. QIAGEN Recent Development
 Table 67. Roche Company Details
 Table 68. Roche Business Overview
 Table 69. Roche Pharmacodynamic (PD) Biomarkers Product
 Table 70. Roche Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025) & (US$ Million)
 Table 71. Roche Recent Development
 Table 72. Danaher Corporation Company Details
 Table 73. Danaher Corporation Business Overview
 Table 74. Danaher Corporation Pharmacodynamic (PD) Biomarkers Product
 Table 75. Danaher Corporation Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025) & (US$ Million)
 Table 76. Danaher Corporation Recent Development
 Table 77. Siemens Healthcare Company Details
 Table 78. Siemens Healthcare Business Overview
 Table 79. Siemens Healthcare Pharmacodynamic (PD) Biomarkers Product
 Table 80. Siemens Healthcare Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025) & (US$ Million)
 Table 81. Siemens Healthcare Recent Development
 Table 82. Abbott Company Details
 Table 83. Abbott Business Overview
 Table 84. Abbott Pharmacodynamic (PD) Biomarkers Product
 Table 85. Abbott Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025) & (US$ Million)
 Table 86. Abbott Recent Development
 Table 87. Agilent Technologies Company Details
 Table 88. Agilent Technologies Business Overview
 Table 89. Agilent Technologies Pharmacodynamic (PD) Biomarkers Product
 Table 90. Agilent Technologies Revenue in Pharmacodynamic (PD) Biomarkers Business (2020-2025) & (US$ Million)
 Table 91. Agilent Technologies Recent Development
 Table 92. Research Programs/Design for This Report
 Table 93. Key Data Information from Secondary Sources
 Table 94. Key Data Information from Primary Sources
 Table 95. Authors List of This Report


List of Figures
 Figure 1. Pharmacodynamic (PD) Biomarkers Picture
 Figure 2. Global Pharmacodynamic (PD) Biomarkers Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmacodynamic (PD) Biomarkers Market Share by Type: 2024 VS 2031
 Figure 4. Exposure Biomarkers Features
 Figure 5. Effect Biomarkers Features
 Figure 6. Susceptibility Biomarkers Features
 Figure 7. Global Pharmacodynamic (PD) Biomarkers Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Pharmacodynamic (PD) Biomarkers Market Share by Application: 2024 VS 2031
 Figure 9. Diagnostics Case Studies
 Figure 10. Drug Discovery Case Studies
 Figure 11. Personalized Medicine Case Studies
 Figure 12. Others Case Studies
 Figure 13. Pharmacodynamic (PD) Biomarkers Report Years Considered
 Figure 14. Global Pharmacodynamic (PD) Biomarkers Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Pharmacodynamic (PD) Biomarkers Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Pharmacodynamic (PD) Biomarkers Market Share by Region: 2024 VS 2031
 Figure 17. Global Pharmacodynamic (PD) Biomarkers Market Share by Players in 2024
 Figure 18. Global Top Pharmacodynamic (PD) Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacodynamic (PD) Biomarkers as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Pharmacodynamic (PD) Biomarkers Revenue in 2024
 Figure 20. North America Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Pharmacodynamic (PD) Biomarkers Market Share by Country (2020-2031)
 Figure 22. United States Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Pharmacodynamic (PD) Biomarkers Market Share by Country (2020-2031)
 Figure 26. Germany Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Share by Region (2020-2031)
 Figure 34. China Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Pharmacodynamic (PD) Biomarkers Market Share by Country (2020-2031)
 Figure 42. Mexico Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Share by Country (2020-2031)
 Figure 46. Turkey Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
 Figure 50. Merck Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
 Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
 Figure 52. QIAGEN Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
 Figure 53. Roche Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
 Figure 54. Danaher Corporation Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
 Figure 55. Siemens Healthcare Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
 Figure 56. Abbott Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
 Figure 57. Agilent Technologies Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global PD 1 and PD L1 Inhibitor Market Research Report 2025
Lateral Flow Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024
Global Fetal Monitoring and Diagnostics Test Market Research Report 2024
Global Parkinson Treatment Drug Market Research Report 2025
Global Diagnostic Guidewire Market Research Report 2024
Pharmacokinetics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Premium Diagnostic Radiology Monitors Market Research Report 2025
Global Cardiac Biomarker Diagnostic Kits Market Research Report 2025
High density Multiplexed Diagnostic Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmacogenomics Technology Theranostics Companion Diagnostics CDx Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Drug Monitoring Test Market Research Report 2025
Pharmacodynamic Biomarker Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmacodynamic Biomarker Assay Market Research Report 2024
Pharmacokinetic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Network Performance Monitoring and Diagnostics NPMD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Automated Clinical Diagnostic System Market Research Report 2024
High throughput Drug Screening Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmacogenomics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions